Delivery Mechanisms for Large Molecule Drugs Successes and failures of leading technologies and key drivers for market success

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

Physician Views: New data for Novartis% LCZ696 set the Street abuzz, but how do cardiologists see it fitting into highly genericised heart failure market?

Physician Views: New data for Novartis% LCZ696 set the Street abuzz, but how do cardiologists see it fitting into highly genericised heart failure market?

  • $ 645
  • Industry report
  • by Firstword Pharma
  • Oct 2014

The potential blockbuster status of Novartis' LCZ696 has seemingly been cemented in the eyes of the Street thanks to solid results from the Phase III PARADIGM-HF study that were presented over the weekend. Indeed, the chronic heart failure agent is believed to represent both a significant growth drive ...

Industries: Pathology | Countries: United States

Chemical & Pharmaceutical Plant Construction in South Africa to 2018: Market Databook

Chemical & Pharmaceutical Plant Construction in South Africa to 2018: Market Databook

  • $ 500
  • Industry report
  • by Timetric
  • October 2014
  • 33 pages

Synopsis Timetric's 'Chemical & Pharmaceutical Plant Construction in South Africa to 2018: Market Databook' contains detailed historic and forecast market value data for the chemical and pharmaceutical plants construction industry, including a breakdown of the data by construction activity (new construction, ...

Industries: Pharmaceutical | Countries: South Africa

Chemical & Pharmaceutical Plants Construction in Austria to 2018: Market Databook

Chemical & Pharmaceutical Plants Construction in Austria to 2018: Market Databook

  • $ 500
  • Industry report
  • by Timetric
  • October 2014
  • 33 pages

Synopsis Timetric's 'Chemical & Pharmaceutical Plants Construction in Austria to 2018: Market Databook' contains detailed historic and forecast market value data for the chemical and pharmaceutical plants construction industry, including a breakdown of the data by construction activity (new construction, ...

Industries: Pharmaceutical | Countries: Austria

Yabao Pharmaceutical Group Company Limited

Yabao Pharmaceutical Group Company Limited

  • $ 55
  • Company report
  • by Wright Investors' Service
  • October 2014
  • 56 pages

A textual analysis of the financial results for Yabao Pharmaceutical Group Company Limited compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. ...

Industries: Pharmaceutical

Aisei Pharmacy Co Ltd

Aisei Pharmacy Co Ltd

  • $ 55
  • Company report
  • by Wright Investors' Service
  • October 2014
  • 53 pages

A textual analysis of the financial results for Aisei Pharmacy Co Ltd compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business description ...

Industries: Pharmacies and Drug Stores

Sam-A Pharmaceutical Company

Sam-A Pharmaceutical Company

  • $ 55
  • Company report
  • by Wright Investors' Service
  • October 2014
  • 56 pages

A textual analysis of the financial results for Sam-A Pharmaceutical Company compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business ...

Industries: Pharmaceutical

Biofermin Pharmaceutical Company Limited

Biofermin Pharmaceutical Company Limited

  • $ 55
  • Company report
  • by Wright Investors' Service
  • October 2014
  • 55 pages

A textual analysis of the financial results for Biofermin Pharmaceutical Company Limited compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. ...

Industries: Pharmaceutical

Nang Kuang Pharmaceutical Co., Ltd

Nang Kuang Pharmaceutical Co., Ltd

  • $ 55
  • Company report
  • by Wright Investors' Service
  • October 2014
  • 56 pages

A textual analysis of the financial results for Nang Kuang Pharmaceutical Co., Ltd compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A ...

Industries: Pharmaceutical

Jiangzhong Pharmaceutical Company Limited

Jiangzhong Pharmaceutical Company Limited

  • $ 55
  • Company report
  • by Wright Investors' Service
  • October 2014
  • 56 pages

A textual analysis of the financial results for Jiangzhong Pharmaceutical Company Limited compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. ...

Industries: Pharmaceutical

Cosmos Pharmaceutical Corporation

Cosmos Pharmaceutical Corporation

  • $ 55
  • Company report
  • by Wright Investors' Service
  • October 2014
  • 54 pages

A textual analysis of the financial results for Cosmos Pharmaceutical Corporation compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A ...

Industries: Pharmaceutical

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 718 618 4302

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.